AI Summary
Thinking
Thinking
We reviewed 5 live results for soliris and narrowed them down to the 3 options that look most worth comparing first.
The options are Soliris (eculizumab), Soliris, and Soliris 10mg/ml Concentrate for Solution for Infusion.
Source: Alexion Pharmaceuticals
Description
Soliris is a prescription monoclonal antibody used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It is a biologic medicine administered via intravenous infusion to help prevent the destruction of red blood cells and other complications of the complement system.
Best for
Rare disease management, Patients with PNH or aHUS, Neuromyelitis optica spectrum disorder and Specialized biologic therapy
Rate this product
Source: AstraZeneca Malaysia
Description
Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases.
Best for
Complement inhibition, Rare immune diseases and Infusion therapy
Rate this product
Source: AstraZeneca Malaysia
Description
Locally registered and approved formulation of Soliris available in Malaysia. This concentrate is intended for intravenous infusion in clinical settings for the treatment of rare conditions such as aHUS and PNH. It is regulated as a scheduled poison by the Malaysian National Pharmaceutical Regulatory Agency (NPRA).
Best for
Malaysian residents, Hospital Based infusion, NPRA Approved prescriptions and Local rare disease support
Rate this product
| Compare | #1Soliris (eculizumab) | #2Soliris | #3Soliris 10mg/ml Concentrate for Solution for Infusion |
|---|---|---|---|
| Source | Alexion Pharmaceuticals | AstraZeneca Malaysia | AstraZeneca Malaysia |
| Description | Soliris is a prescription monoclonal antibody used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It is a biologic medicine administered via intravenous infusion to help prevent the destruction of red blood cells and other complications of the complement system. | Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases. | Locally registered and approved formulation of Soliris available in Malaysia. This concentrate is intended for intravenous infusion in clinical settings for the treatment of rare conditions such as aHUS and PNH. It is regulated as a scheduled poison by the Malaysian National Pharmaceutical Regulatory Agency (NPRA). |
| Best for | Rare disease management, Patients with PNH or aHUS, Neuromyelitis optica spectrum disorder and Specialized biologic therapy | Complement inhibition, Rare immune diseases and Infusion therapy | Malaysian residents, Hospital Based infusion, NPRA Approved prescriptions and Local rare disease support |
| Action | Soliris (eculizumab) | Soliris | Soliris 10mg/ml Concentrate for Solution for Infusion |
| Rate this product |
"Soliris (eculizumab) from Alexion Pharmaceuticals."
TopFind picked this because As the original manufacturer, Alexion provides the most comprehensive safety protocols and patient support through programs like OneSource.
Note: TopFind provides comparison information for general research purposes only.